Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 58460

1.

A2aR antagonists: Next generation checkpoint blockade for cancer immunotherapy.

Leone RD, Lo YC, Powell JD.

Comput Struct Biotechnol J. 2015 Apr 8;13:265-72. doi: 10.1016/j.csbj.2015.03.008. eCollection 2015. Review.

PMID:
25941561
2.

Continuous non-invasive monitoring to detect covert autonomic dysfunction in Parkinson's disease.

Hellman AM, Shah SP, Pawlowski SM, Duda JE, Morley JF.

Parkinsonism Relat Disord. 2015 Apr 23. pii: S1353-8020(15)00164-9. doi: 10.1016/j.parkreldis.2015.04.016. [Epub ahead of print]

PMID:
25940998
3.

The dormant blood microbiome in chronic, inflammatory diseases.

Potgieter M, Bester J, Kell DB, Pretorius E.

FEMS Microbiol Rev. 2015 May 3. pii: fuv013. [Epub ahead of print] Review.

PMID:
25940667
4.

How do people live life successfully with Parkinson's disease?

Kang MY, Ellis-Hill C.

J Clin Nurs. 2015 May 4. doi: 10.1111/jocn.12819. [Epub ahead of print]

PMID:
25939827
5.

Levodopa-carbidopa intrajejunal gel in advanced Parkinson disease with "on" freezing of gait.

Cossu G, Ricchi V, Pilleri M, Mancini F, Murgia D, Ricchieri G, Mereu A, Melis M, Antonini A.

Neurol Sci. 2015 May 5. [Epub ahead of print]

PMID:
25939726
6.

Structural and Functional Impact of Parkinson Disease-Associated Mutations in the E3 Ubiquitin Ligase Parkin.

Fiesel FC, Caulfield TR, Moussaud-Lamodière EL, Dourado KO, Flores SC, Ross OA, Springer W.

Hum Mutat. 2015 May 5. doi: 10.1002/humu.22808. [Epub ahead of print]

PMID:
25939424
7.

Groundwater Pesticide Levels and the Association With Parkinson Disease.

James KA, Hall DA.

Int J Toxicol. 2015 May 4. pii: 1091581815583561. [Epub ahead of print]

PMID:
25939349
8.

Copper binding to the N-terminally acetylated, naturally occurring form of alpha-synuclein induces local helical folding.

Miotto MC, Valiente-Gabioud AA, Rossetti G, Zweckstetter M, Carloni P, Selenko P, Griesinger C, Binolfi A, Fernandez CO.

J Am Chem Soc. 2015 May 4. [Epub ahead of print]

PMID:
25939020
9.

Weight loss and impact on quality of life in Parkinson's disease.

Akbar U, He Y, Dai Y, Hack N, Malaty I, McFarland NR, Hess C, Schmidt P, Wu S, Okun MS.

PLoS One. 2015 May 4;10(5):e0124541. doi: 10.1371/journal.pone.0124541. eCollection 2015.

PMID:
25938478
10.

Alterations in the limbic/paralimbic cortices of Parkinson's disease patients with hyposmia under resting-state functional MRI by regional homogeneity and functional connectivity analysis.

Su M, Wang S, Fang W, Zhu Y, Li R, Sheng K, Zou D, Han Y, Wang X, Cheng O.

Parkinsonism Relat Disord. 2015 Apr 18. pii: S1353-8020(15)00154-6. doi: 10.1016/j.parkreldis.2015.04.006. [Epub ahead of print]

PMID:
25937615
11.

Nesfatin-1 Antagonized Rotenone-Induced Neurotoxicity in MES23.5 Dopaminergic Cells.

Tan Z, Xu H, Shen X, Jiang H.

Peptides. 2015 Apr 30. pii: S0196-9781(15)00138-2. doi: 10.1016/j.peptides.2015.04.019. [Epub ahead of print]

PMID:
25937598
12.

The role of TREM2 R47H as a risk factor for Alzheimer's disease, frontotemporal lobar degeneration, amyotrophic lateral sclerosis, and Parkinson's disease.

Lill CM, Rengmark A, Pihlstrøm L, Fogh I, Shatunov A, Sleiman PM, Wang LS, Liu T, Lassen CF, Meissner E, Alexopoulos P, Calvo A, Chio A, Dizdar N, Faltraco F, Forsgren L, Kirchheiner J, Kurz A, Larsen JP, Liebsch M, Linder J, Morrison KE, Nissbrandt H, Otto M, Pahnke J, Partch A, Restagno G, Rujescu D, Schnack C, Shaw CE, Shaw PJ, Tumani H, Tysnes OB, Valladares O, Silani V, van den Berg LH, van Rheenen W, Veldink JH, Lindenberger U, Steinhagen-Thiessen E; SLAGEN Consortium, Teipel S, Perneczky R, Hakonarson H, Hampel H, von Arnim CA, Olsen JH, Van Deerlin VM, Al-Chalabi A, Toft M, Ritz B, Bertram L.

Alzheimers Dement. 2015 Apr 29. pii: S1552-5260(15)00122-3. doi: 10.1016/j.jalz.2014.12.009. [Epub ahead of print]

PMID:
25936935
13.

The closing-in phenomenon in Parkinson's disease.

De Lucia N, Trojano L, Vitale C, Grossi D, Barone P, Santangelo G.

Parkinsonism Relat Disord. 2015 Apr 22. pii: S1353-8020(15)00161-3. doi: 10.1016/j.parkreldis.2015.04.013. [Epub ahead of print]

PMID:
25936264
14.

Chronic manganism: A long-term follow-up study with a new dopamine terminal biomarker of 18F-FP-(+)-DTBZ (18F-AV-133) brain PET scan.

Huang CY, Liu CH, Tsao E, Hsieh CJ, Weng YH, Hsiao IT, Yen TC, Lin KJ, Huang CC.

J Neurol Sci. 2015 Apr 17. pii: S0022-510X(15)00215-4. doi: 10.1016/j.jns.2015.04.018. [Epub ahead of print]

PMID:
25936253
15.

Chronological changes of 123I-MIBG myocardial scintigraphy and clinical features of Parkinson's disease.

Tsujikawa K, Hasegawa Y, Yokoi S, Yasui K, Nanbu I, Yanagi T, Takahashi A.

J Neurol Neurosurg Psychiatry. 2015 May 2. pii: jnnp-2015-310327. doi: 10.1136/jnnp-2015-310327. [Epub ahead of print]

PMID:
25935888
16.

Fast vergence eye movements are disrupted in Parkinson's disease: A video-oculography study.

Hanuška J, Bonnet C, Rusz J, Sieger T, Jech R, Rivaud-Péchoux S, Vidailhet M, Gaymard B, Růžička E.

Parkinsonism Relat Disord. 2015 Apr 23. pii: S1353-8020(15)00162-5. doi: 10.1016/j.parkreldis.2015.04.014. [Epub ahead of print]

PMID:
25935708
17.

Characterization of long-term motor deficits in the 6-OHDA model of Parkinson's disease in the common marmoset.

Santana M, Palmér T, Simplício H, Fuentes R, Petersson P.

Behav Brain Res. 2015 Apr 28. pii: S0166-4328(15)00286-7. doi: 10.1016/j.bbr.2015.04.037. [Epub ahead of print]

PMID:
25934488
18.

Postoperative apathy can neutralise benefits in quality of life after subthalamic stimulation for Parkinson's disease.

Martinez-Fernandez R, Pelissier P, Quesada JL, Klinger H, Lhommée E, Schmitt E, Fraix V, Chabardes S, Mertens P, Castrioto A, Kistner A, Broussolle E, Pollak P, Thobois S, Krack P.

J Neurol Neurosurg Psychiatry. 2015 Apr 30. pii: jnnp-2014-310189. doi: 10.1136/jnnp-2014-310189. [Epub ahead of print]

PMID:
25934016
19.

Role of mTOR inhibitors in epilepsy treatment.

Sadowski K, Kotulska-Jóźwiak K, Jóźwiak S.

Pharmacol Rep. 2015 Jun;67(3):636-646. doi: 10.1016/j.pharep.2014.12.017. Epub 2015 Jan 14. Review.

PMID:
25933981
20.

TDP-43 Pathology Progression Along the Olfactory Pathway as a Possible Substrate for Olfactory Impairment in Amyotrophic Lateral Sclerosis.

Takeda T, Iijima M, Uchihara T, Ohashi T, Seilhean D, Duyckaerts C, Uchiyama S.

J Neuropathol Exp Neurol. 2015 Apr 30. [Epub ahead of print]

PMID:
25933387
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk